Trump's fervor for an unproven COVID-19 drug is reportedly fueled by Rudy Giuliani, Dr. Oz

President Trump is very excited about hydroxychloroquine as a treatment for COVID-19, frequently touting it as a "game changer," and he isn't alone in his enthusiasm. His economic adviser Peter Navarro, who reportedly sparred with top U.S. infectious disease expert Dr. Anthony Fauci about hydroxychloroquine, told Fox & Friends on Monday morning he would "bet on President Trump's intuition on this." Other boosters Trump is apparently listening to include his lawyer Rudy Giuliani and Dr. Mehmet Oz, the controversial television personality.
At Sunday night's press briefing, Trump said he hopes doctors use the drug, "because I'll tell you what, what do you have to lose?" He added: "I may take it. I'll have to ask my doctors about that." When a reporter asked Fauci about hydroxychloroquine, Trump stepped in and shut it down.
Most health officials and medical scientists, like Fauci, are unconvinced about the malaria drug's effectiveness at treating the coronavirus, noting that the evidence so far is anecdotal and contradictory. "I think we've got to be careful that we don't make that majestic leap to assume that this is a knockout drug," Fauci said on Friday's Fox & Friends. Hydroxychloroquine also has heath risks, including cardiac arrest in some cases.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Giuliani has been pushing hydroxychloroquine on Twitter, his podcast, and, he tells The Washington Post, in one-on-one calls with Trump. He said he has no financial stake in hydroxychloroquine. After watching Dr. Oz repeatedly tout the drug on Fox News, Trump said he wants to speak with Oz and told health officials it would be "a good idea" if they did, too, The Daily Beast reports. At least one official, Medicare administrator Seema Verma, spoke with Oz privately.
In mid-March, Reuters reports, "Trump personally pressed federal health officials" to green-light hydroxychloroquine as a COVID-19 treatment, and "shortly afterward, the federal government published highly unusual guidance informing doctors they had the option to prescribe the drugs, with key dosing information based on unattributed anecdotes rather than peer-reviewed science." When asked about its guidance, the Centers for Disease Control and Prevention said Trump's coronavirus task force had requested the document.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
The Week Unwrapped: Why are sinkholes becoming more common?
Podcast Plus, will Saudi investment help create the "Netflix of sport"? And why has New Zealand's new tourism campaign met with a savage reception?
By The Week UK Published
-
How Poland became Europe's military power
The Explainer Warsaw has made its armed forces a priority as it looks to protect its borders and stay close to the US
By Elizabeth Carr-Ellis, The Week UK Published
-
Quiz of The Week: 15 - 21 February
Have you been paying attention to The Week's news?
By The Week Staff Published
-
Trump's China tariffs start after Canada, Mexico pauses
Speed Read The president paused his tariffs on America's closest neighbors after speaking to their leaders, but his import tax on Chinese goods has taken effect
By Peter Weber, The Week US Published
-
Chinese AI chatbot's rise slams US tech stocks
Speed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
By Peter Weber, The Week US Published
-
US port strike averted with tentative labor deal
Speed Read The strike could have shut down major ports from Texas to Maine
By Peter Weber, The Week US Published
-
Biden expected to block Japanese bid for US Steel
Speed Read The president is blocking the $14 billion acquisition of U.S. Steel by Japan's Nippon Steel, citing national security concerns
By Peter Weber, The Week US Published
-
Judges block $25B Kroger-Albertsons merger
Speed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
By Peter Weber, The Week US Published
-
Rupert Murdoch loses 'Succession' court battle
Speed Read Murdoch wanted to give full control of his empire to son Lachlan, ensuring Fox News' right-wing editorial slant
By Peter Weber, The Week US Published
-
Bitcoin surges above $100k in post-election rally
Speed Read Investors are betting that the incoming Trump administration will embrace crypto
By Peter Weber, The Week US Published
-
Enron mystery: 'sick joke' or serious revival?
Speed Read 23 years after its bankruptcy filing, the Texas energy firm has announced its resurrection
By Peter Weber, The Week US Published